Curia Global Inc., a global contract research, development, and manufacturing organization (CDMO), announced the completion of a USD 5.61 million investment in its León, Spain, operations, adding a new precision fermentation facility and increasing the site's capacity to 58,000 liters.
A New Precision Fermentation Facility
The project, announced from Albany, supports a new precision fermentation facility for development and scale-up activities through capacity enablement and upgraded site utilities.
As part of the initiative, Curia built a facility with fermentation (USP) and downstream processing (DSP) equipment to enable optimized manufacturing flows.
New equipment installations will increase the facility's capacity to 58,000 L.
Utility Upgrades to Support Production
To fully support the new production building, the project includes the installation of critical utility systems. According to the company, these upgrades are designed to provide a reliable utility supply across production operations.
Jamie Grabowski, President of R&D at Curia, said the company is committed to supporting customers with reliable, efficient manufacturing and flexible capacity as programs advance.
"By aligning our equipment footprint and upgrading essential utilities, we are building a strong foundation for sustained performance at León," Grabowski said.
Trusted by Leading EPCs & Manufacturers
Find the Latest Pharmaceutical Plant Projects in Spain
Gain exclusive access to our industry-leading database of pharmaceutical plant opportunities with detailed project timelines and stakeholder information
Request Free Trial → Learn More →
No credit card Up-to-date coverage
León's Role in Curia's Network
Curia's León facility specializes in biotechnology development, fermentation production, and downstream processing for customers across the pharmaceutical, cosmetic, agriculture, and food industries.
The company describes the expansion as a reflection of its continued focus on strengthening its manufacturing network and ensuring that sites are equipped to meet evolving customer needs through dependable operations and high standards of quality.
About Curia
Curia is a CDMO with over 30 years of experience, an integrated network of more than 20 global sites, and 3,100 employees partnering with biopharmaceutical customers to bring therapies to market.
Its offerings in small molecules, generic APIs, and biologics span discovery through commercialization, with integrated regulatory, analytical, and sterile fill-finish capabilities. The company provides services across drug substance and drug product manufacturing.
Stay Ahead of Spain's Chemical Plant Boom
Spain's chemical sector is entering a decisive phase, with billions flowing into green hydrogen hubs, petrochemical expansions, and specialty plant retrofits. The question isn't whether these projects will reshape supply chains; it's whether your business will be ready to seize the opportunities they create.
Tracking announcements across national regulators, environmental agencies, and trade publications is a full-time job in itself. Fragmented data leads to missed tenders, late bids, and lost contracts. What you need is a single, reliable pipeline of intelligence covering every project milestone across the region.
This is precisely where the Global Project Tracking (GPT) platform by Blackridge Research makes the difference. It consolidates chemical sector project intelligence across Spain into one actionable dashboard, so your team spends time winning work instead of hunting for it.
Upcoming Projects
Tender Notices
Contract Awards
Projects Under Construction
Completed Projects
Ready to see Spain's chemical project pipeline in one place? Book a Free Demo of the Global Project Tracking (GPT) platform by Blackridge Research today.
Leave a Comment
We love hearing from our readers and value your feedback. If you have any questions or comments about our content, feel free to leave a comment below.
We read every comment and do our best to respond to them all.